Biogen_Logo_Standard-rgb_R.jpg
Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European Commission
December 19, 2023 07:30 ET | Biogen Inc.
CAMBRIDGE, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the European Commission has revoked the centralized marketing authorizations for generic versions...
Future Market Insights.png
The Growth Trajectory Topical Pain Relief Market Set to Hit US$ 17,115.4 Million by 2034, Riding on a Strong 5.3% CAGR | Future Market Insights, Inc.
December 19, 2023 07:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 19, 2023 (GLOBE NEWSWIRE) -- As per Future Market Insights (FMI) industry analysis, the valuation for the global topical pain relief market is US$ 10,720.8 million in 2024. It is...
XOMA royalty-2c.png
XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties
December 19, 2023 07:30 ET | XOMA Corporation
Low-cost financing capitalizes on XOMA’s $14 million acquisition of VABYSMO® (faricimab) royalties in 2021 Proceeds expected to be used for stock repurchases and additional royalty and milestone...
fuelcellenergy-primary-logo-full-color-rgb-864px@72ppi.jpg
FuelCell Energy Reports Fourth Quarter and Full Fiscal Year 2023 Results
December 19, 2023 07:30 ET | FuelCell Energy, Inc.
Fourth Quarter Fiscal 2023 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenues of $22.5 million compared to $39.2 millionGross loss of $(1.5) million...
LOGO KNIGHT 256X256px.jpg
Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in Canada
December 19, 2023 07:30 ET | Knight Therapeutics
MONTREAL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an...
AYR-Blue-RGB.jpg
AYR Cannabis Dispensary Announces Opening of Two New Dispensaries in Florida
December 19, 2023 07:30 ET | Ayr Wellness Inc.
MIAMI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- AYR Cannabis Dispensary, a cannabis retail chain owned by AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically...
AnavexLogoR-Transparent @3x.png
Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer’s Disease
December 19, 2023 07:30 ET | Anavex Life Sciences Corp.
NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
revi.jpg
Revival Gold Intersects Oxidized Mineralization in Previously Untested Targets at Beartrack-Arnett
December 19, 2023 07:30 ET | Revival Gold Inc.
TORONTO, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), is pleased to report results from the final eight core holes completed in...
MnM_logo_TM_JPG.JPG
Clinical Trial Supplies Market is Expected to Reach $6.3 Billion | MarketsandMarkets.
December 19, 2023 07:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Clinical Trial Supplies market in terms of revenue was estimated to be worth $3.9 Billion in 2023 and is poised to reach $6.3 billion by 2028, growing at a...
DevvStream Holdings Inc..png
DevvStream Provides Corporate Update Outlining Accelerated Development of Market-Leading Carbon Credit Platform
December 19, 2023 07:30 ET | DevvStream
VANCOUVER, British Columbia, Dec. 19, 2023 (GLOBE NEWSWIRE) -- DevvStream Holdings Inc. (“DevvStream” or the “Company”) (CBOE: DESG) (OTCQB: DSTRF) (FSE: CQ0), a leading carbon credit project...